Effect of substituents on arene oxide-mediated liver toxicity among substituted bromobenzenes. 1977

E G Toranzo, and T Gillesse, and M Mendenhall, and G J Traiger, and P G Riley, and R P Hanzlik, and R A Wiley

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008107 Liver Diseases Pathological processes of the LIVER. Liver Dysfunction,Disease, Liver,Diseases, Liver,Dysfunction, Liver,Dysfunctions, Liver,Liver Disease,Liver Dysfunctions
D008297 Male Males
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D001969 Bromobenzenes Derivatives of benzene in which one or more hydrogen atoms on the benzene ring are replaced by bromine atoms.
D000410 Alanine Transaminase An enzyme that catalyzes the conversion of L-alanine and 2-oxoglutarate to pyruvate and L-glutamate. (From Enzyme Nomenclature, 1992) EC 2.6.1.2. Alanine Aminotransferase,Glutamic-Pyruvic Transaminase,SGPT,Alanine-2-Oxoglutarate Aminotransferase,Glutamic-Alanine Transaminase,Alanine 2 Oxoglutarate Aminotransferase,Aminotransferase, Alanine,Aminotransferase, Alanine-2-Oxoglutarate,Glutamic Alanine Transaminase,Glutamic Pyruvic Transaminase,Transaminase, Alanine,Transaminase, Glutamic-Alanine,Transaminase, Glutamic-Pyruvic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus
D056486 Chemical and Drug Induced Liver Injury A spectrum of clinical liver diseases ranging from mild biochemical abnormalities to ACUTE LIVER FAILURE, caused by drugs, drug metabolites, herbal and dietary supplements and chemicals from the environment. Drug-Induced Liver Injury,Liver Injury, Drug-Induced,Acute Liver Injury, Drug-Induced,Chemically-Induced Liver Toxicity,Drug-Induced Acute Liver Injury,Drug-Induced Liver Disease,Hepatitis, Drug-Induced,Hepatitis, Toxic,Liver Injury, Drug-Induced, Acute,Toxic Hepatitis,Acute Liver Injury, Drug Induced,Chemically Induced Liver Toxicity,Chemically-Induced Liver Toxicities,Disease, Drug-Induced Liver,Diseases, Drug-Induced Liver,Drug Induced Acute Liver Injury,Drug Induced Liver Disease,Drug Induced Liver Injury,Drug-Induced Hepatitides,Drug-Induced Hepatitis,Drug-Induced Liver Diseases,Drug-Induced Liver Injuries,Hepatitides, Drug-Induced,Hepatitides, Toxic,Hepatitis, Drug Induced,Injuries, Drug-Induced Liver,Injury, Drug-Induced Liver,Liver Disease, Drug-Induced,Liver Diseases, Drug-Induced,Liver Injuries, Drug-Induced,Liver Injury, Drug Induced,Liver Toxicities, Chemically-Induced,Liver Toxicity, Chemically-Induced,Toxic Hepatitides,Toxicities, Chemically-Induced Liver,Toxicity, Chemically-Induced Liver

Related Publications

E G Toranzo, and T Gillesse, and M Mendenhall, and G J Traiger, and P G Riley, and R P Hanzlik, and R A Wiley
June 1979, Toxicology and applied pharmacology,
E G Toranzo, and T Gillesse, and M Mendenhall, and G J Traiger, and P G Riley, and R P Hanzlik, and R A Wiley
January 1981, Advances in experimental medicine and biology,
E G Toranzo, and T Gillesse, and M Mendenhall, and G J Traiger, and P G Riley, and R P Hanzlik, and R A Wiley
June 1983, Toxicology and applied pharmacology,
E G Toranzo, and T Gillesse, and M Mendenhall, and G J Traiger, and P G Riley, and R P Hanzlik, and R A Wiley
January 1988, Drug metabolism and disposition: the biological fate of chemicals,
E G Toranzo, and T Gillesse, and M Mendenhall, and G J Traiger, and P G Riley, and R P Hanzlik, and R A Wiley
April 2009, The Journal of organic chemistry,
E G Toranzo, and T Gillesse, and M Mendenhall, and G J Traiger, and P G Riley, and R P Hanzlik, and R A Wiley
December 1976, Chemical & pharmaceutical bulletin,
E G Toranzo, and T Gillesse, and M Mendenhall, and G J Traiger, and P G Riley, and R P Hanzlik, and R A Wiley
January 1969, Justus Liebigs Annalen der Chemie,
E G Toranzo, and T Gillesse, and M Mendenhall, and G J Traiger, and P G Riley, and R P Hanzlik, and R A Wiley
May 2011, Organic & biomolecular chemistry,
E G Toranzo, and T Gillesse, and M Mendenhall, and G J Traiger, and P G Riley, and R P Hanzlik, and R A Wiley
September 2013, Chemical communications (Cambridge, England),
E G Toranzo, and T Gillesse, and M Mendenhall, and G J Traiger, and P G Riley, and R P Hanzlik, and R A Wiley
July 2007, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!